| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | C |
| 6. Replicate Analysis | B |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | B |
| 15. Total Score | C5,7,8,10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | 24 Hour Urine |
| Measurand | N-telopeptide crosslinks (NTx) |
| Unit | Unknown / Unknown |
| Overall Analytical Principle Method | Immunoassay; ELISA |
| Number of Subjects | 10 |
| Number of Subjects included in BV estimation | 5 |
| Ethinicity | Unknown |
| Age Mean / Median | |
| Age Min | 23.0 |
| Age Max | 44.0 |
| Age SD | |
| Number of Males | 5 |
| Number of Females | 5 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 5 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Day |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 5 |
| Average Number of Samples Used for BV Estimation | 5.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 17.0 |
| Calculated Confidence Intervals of CVi | Lower: 12.63, Upper: 25.01 |
| Estimates of CVg | 52.0 |
| Calculated Confidence Intervals of CVg | Lower: 31.84, Upper: 128.74 |
| Analytical CV | 6.5 |
| Calculated Confidence Intervals of Analytical CV | Lower: 5.10, Upper: 8.97 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |